Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents. N Engl J Med 2018; 379:913 [MEDLINE]
A Step Forward in the Treatment of Influenza. N Engl J Med. 2018 Sep 6;379(10):975-977. doi: 10.1056/NEJMe1810815 [MEDLINE]
Roche media release. Phase III CAPSTONE-2 study showed that baloxavir marboxil reduced symptoms in people at high risk of complications from the flu. https://www.roche.com/media/releases/med-cor-2018-07-17.htm (Accessed on September 08, 2018)
Baloxavir: First Global Approval. Drugs 2018; 78:693
